Navigation Links
REMINDER: Exelixis Will Webcast Its June 2 Investor and Analyst Briefing at ASCO
Date:5/28/2008

Seven Abstracts Accepted for Presentation at ASCO

SOUTH SAN FRANCISCO, Calif., May 28 /PRNewswire-FirstCall/ -- Exelixis, Inc. (Nasdaq: EXEL) will hold an investor and analyst briefing in conjunction with the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) from 6:00 p.m. to 8:00 p.m. CT on Monday, June 2, 2008.

Participants:

-- George A. Scangos, PhD, President and Chief Executive Officer

-- Michael M. Morrissey, PhD, President of Research and Development

-- Gisela M. Schwab, MD, Executive Vice President and Chief Medical

Officer

Topics:

-- XL184 (targets: MET, VEGFR2, RET)

-- XL147 (targets: PI3K)

-- XL765 (targets: PI3K, mTOR)

-- XL647 (targets: EGFR, HER2, VEGFR2)

-- XL880* (targets: MET, VEGFR2)

-- XL281 (targets: RAF)

* XL880 was selected by GlaxoSmithKline in December 2007 for further

development and commercialization.

The event will be webcast and may be accessed in the Event Calendar page under Investors at http://www.exelixis.com.

An archived replay of this webcast will be available until 9:00 p.m. PT/12:00 a.m. ET on July 2, 2008. Access numbers for this replay are: 1-888-286-8010 (domestic) and +1-617-801-6888 (international); the replay passcode is: 42662164.

ASCO Presentations

Saturday, May 31

-- XL647 (EGFR, HER2, VEGFR2) -- Poster & Discussion

"A phase 1 study of XL647, an EGFR, HER2, VEGFR2 inhibitor,

administered orally daily to patients (pts) with advanced solid

malignancies (ASM)"

Day: Saturday, May 31

Session: Developmental Therapeutics: Molecula
'/>"/>

SOURCE Exelixis, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Reminder: XTL to Hold a Conference Call Today at 8:30 am EDT to Discuss the Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain
2. Reminder: Exelixis Announces December 5 Webcast of Its Third Annual R&D Day
3. Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation
4. Exelixis Reports Encouraging Interim Data From a Phase 2 Trial of XL647 as First-Line Therapy for Non-Small Cell Lung Cancer
5. Exelixis Announces Closing of Public Offering of Common Stock
6. Exelixis Submits XL880 Diligence Report to GlaxoSmithKline
7. Exelixis Announces November 5 Webcast of its 2007 Third Quarter Financial Results Conference Call
8. Exelixis Announces Third Quarter 2007 Financial Results and Business Update
9. Exelixis Sells 80% Stake in Artemis to Taconic
10. Exelixis Announces December 5 Webcast of Its Third Annual R&D Day
11. Exelixis Announces November 27 Webcast of Presentation at the 19th Annual Piper Jaffray Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... May 22, 2013 Cambridge Semantics ... last week’s “Data Demonstration Day” on Capitol Hill, hosted by ... EMC, Google, Microsoft and others to showcase how innovative data ... Accountability and Transparency Act (DATA Act). , Originally introduced in ... (R-CA) and Sen. Mark Warner (D-VA ), ...
(Date:5/22/2013)... ORLEANS , May 22, 2013  Organogenesis Inc., ... presented new data generated in collaboration with a team ... economics consultancy) demonstrating the significant healthcare resource and economic ... ulcers (VLU) place upon the US healthcare system. ... annual costs of up to $15 billion and $18 ...
(Date:5/22/2013)... 22, 2013 Express Diagnostics Int’l, ... Ltd are pleased to announce a sponsorship agreement ... and New Zealand distributor of DrugCheck® onsite testing devices, ... participated in the Austin 400 May 17-19 in Austin, ... agreement that involves each car of the Erebus Motorsport ...
(Date:5/22/2013)... CAMBRIDGE, Mass. , May 22, 2013  Moderna ... revolutionary new treatment modality to enable the in ... John Reynders will join Moderna ... Reynders is a proven leader in ... phases of drug development, from discovery to translation, clinical ...
Breaking Biology Technology:Cambridge Semantics Underscores Need for Smart Data during “Data Demonstration Day” on Capitol Hill 2Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 2Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 3Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 4Australian Distributor of Express Diagnostics Signs Sponsorship Agreement with V8 Supercar Team 2Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer 2Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer 3
... SEATTLE, April 22 Trubion Pharmaceuticals, Inc. (Nasdaq: ... preclinical data regarding its SCORPION(TM) multispecific therapeutic technology ... Association of Cancer Research (AACR) in Denver. The ... of the bispecific CD79BxDR SCORPION molecule, its differentiation ...
... tasting rooms really help generate sales for wineries? According ... almost half of winery tasting room visitors purchase the ... "This research proves that the tasting room experience does ... sales," said Dr. Isabelle Lesschaeve, research director, consumer insights ...
... Microtest Laboratories ( www.microtestlabs.com ... to expand its position as a proven, one-stop provider ... services for manufacturers of medical devices or pharmaceuticals.Microtest ... ensure regulatory compliance as well as to achieve greater ...
Cached Biology Technology:Trubion Presents Preclinical Data on Its SCORPION(TM) Multispecific Therapeutics at the 2009 American Association of Cancer Research Annual Meeting 2Trubion Presents Preclinical Data on Its SCORPION(TM) Multispecific Therapeutics at the 2009 American Association of Cancer Research Annual Meeting 3Trubion Presents Preclinical Data on Its SCORPION(TM) Multispecific Therapeutics at the 2009 American Association of Cancer Research Annual Meeting 4Setting the Benchmark for Winery Tasting Room Research: An Emerging Region Gets a Global Perspective 2Microtest Labs Expands Clean Room, Contamination Testing Services 2Microtest Labs Expands Clean Room, Contamination Testing Services 3Microtest Labs Expands Clean Room, Contamination Testing Services 4
(Date:5/21/2013)... long time that some creatures evolve more quickly than ... But it may be that height plays a role, ... U. S. National Evolutionary Synthesis Center. , In ... journal Nature Communications , Lanfear and colleagues report ... a database of global patterns in plant height for ...
(Date:5/21/2013)... the nation,s land and water resources could likely support ... 25 billion gallons of algae-based fuel a year in ... , The findings come from an in-depth look at ... significant amounts of algae in large, specially built shallow ... issue of Environmental Science and Technology , published ...
(Date:5/21/2013)... new method for delivering molecules into single, targeted ... The technique could find applications in drug delivery, ... electroporation a technique used to deliver molecules ... membrane that are caused by exposing them to ... of cell transfection. (Cell transfection is the introduction ...
Breaking Biology News(10 mins):Small but speedy: Short plants live in the evolutionary fast lane 2Going green: Nation equipped to grow serious amounts of pond scum for fuel 2Going green: Nation equipped to grow serious amounts of pond scum for fuel 3Going green: Nation equipped to grow serious amounts of pond scum for fuel 4Single-cell transfection tool enables added control for biological studies 2
... of Warwick scientists have discovered a "nourishing gene" which ... - a significant step which could help increase global ... of Warwick in collaboration with the University of Oxford ... the first time a gene, named Meg1, which regulates ...
... unexpected allies in our efforts to keep hazardous lead under ... transform lead into its most stable mineral form. The findings ... a Cell Press publication, suggest that this interaction between fungi ... are found together. It also suggests that the introduction or ...
... Bethesda, MDNew research published online in the FASEB Journal ... of bacteria in the intestines may be used to predict ... manipulating these organisms may help reduce heart attack risk. This ... physicians use to prevent and treat heart attacks. In addition, ...
Cached Biology News:Discovery of plant 'nourishing gene' brings hope for increased crop seed yield and food security 2In tackling lead pollution, fungi may be our friends 2The microbiome and disease: Gut bacteria influence the severity of heart attacks in rats 2
2 ml SmartScan Racks...
Leptin Receptor Polyclonal Ab 100 ug purified rabbit anti-mouse Leptin Receptor. Tested in Western blotting....
... a compact, highly versatile power supply. Capable of ... this power supply is ideal for PAGE, SDS-PAGE, ... all types of small format transfer apparatus. It ... constant current with a continuously variable output in ...
... PLAU N-term Antibody This antibody is generated ... synthetic peptide selected within aa 50~150 of ... in PBS with 0.09% (W/V) sodium azide. ... G column and eluted out with both ...
Biology Products: